Beijing Biostar Pharmaceuticals (02563) Announces November 2025 Monthly Return on Securities Movements

Bulletin Express
2025/12/03

Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 02563) released its monthly return for the period ended 30 November 2025. The company’s total registered share capital remains RMB 364,588,000, comprising 216,720,857 H shares listed on the Hong Kong Stock Exchange and 147,867,143 unlisted shares, each with a par value of RMB 1.

The announcement indicates no changes to the issued share capital during the reporting month. Both categories of shares maintained the same balance as at the close of the preceding month. No share options, warrants, convertible securities, or other arrangements affected the company’s share capital within this period. The document was submitted on 03 December 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10